[Reversible posterior leukoencephalopathy secondary to treatment with tacrolimus].
Pérez Menéndez-Conde
C
C
Alvarez Díaz
A
A
Delgado Silveira
E
E
Bermejo Vicedo
T
T
D000368:Aged; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced*; D016559:Tacrolimus / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D016559:Tacrolimus